229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.73%
Positive revenue growth while VUZI is negative. John Neff might see a notable competitive edge here.
-3.08%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
1.75%
EBIT growth below 50% of VUZI's 11.13%. Michael Burry would suspect deeper competitive or cost structure issues.
1.75%
Operating income growth under 50% of VUZI's 10.47%. Michael Burry would be concerned about deeper cost or sales issues.
5.26%
Net income growth under 50% of VUZI's 11.25%. Michael Burry would suspect the firm is falling well behind a key competitor.
5.26%
EPS growth at 50-75% of VUZI's 9.09%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
5.26%
Diluted EPS growth at 50-75% of VUZI's 9.09%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
0.61%
Share count expansion well above VUZI's 0.33%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
2.37%
Diluted share count expanding well above VUZI's 0.33%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-95.24%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-783.33%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-39.46%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-33.64%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-24.61%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-99.57%
Negative 10Y OCF/share CAGR while VUZI stands at 60.75%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-98.70%
Negative 5Y OCF/share CAGR while VUZI is at 51.30%. Joel Greenblatt would question the firm’s operational model or cost structure.
-99.43%
Negative 3Y OCF/share CAGR while VUZI stands at 12.89%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-79.43%
Negative 10Y net income/share CAGR while VUZI is at 33.50%. Joel Greenblatt sees a major red flag in long-term profit erosion.
102.81%
5Y net income/share CAGR above 1.5x VUZI's 14.04%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-77.14%
Negative 3Y CAGR while VUZI is 36.24%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
33.65%
Positive growth while VUZI is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
129.69%
Positive 5Y equity/share CAGR while VUZI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
42.40%
Positive short-term equity growth while VUZI is negative. John Neff sees a strong advantage in near-term net worth buildup.
-100.00%
Cut dividends over 10 years while VUZI stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
29.32%
Our AR growth while VUZI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
13.04%
We show growth while VUZI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.32%
Asset growth at 50-75% of VUZI's 3.19%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
0.59%
Under 50% of VUZI's 2.76%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-1.27%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-1.77%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-6.57%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.
